secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-09-05T23:59:59+00:00
Accession:  0001640334-25-001642
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences closes $3M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Closed underwritten offering of 640,924 shares at $4.40/share and 40,894 pre-funded warrants at $4.399 each.
- Gross proceeds of ~$3.0 million; underwriter has 45-day option for an additional 102,272 shares.
- Net proceeds to advance preclinical/clinical development of product candidates and for working capital.
- R.F. Lafferty & Co. acted as sole book-running manager; offering closed on September 5, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001642/0001640334-25-001642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001642/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer